dr. S.F. Oosting

Faculteit Medische Wetenschappen/UMCG

Telefoon:

050 361 3411

E-mail:

s.oosting umcg.nl

ORCID Research Portal

Publicaties

ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours

EnLiST, Saini, K. S., Koopman, M., Martins-Branco, D., Bossi, P., Winther, S. B., Brahmi, M., Braña, I., Calvo, E., Castelo-Branco, L., Colombo, I., de Azambuja, E., De Ruysscher, D., Dienstmann, R., Dingemans, A.-M. C., Ekholm, M., Gallois, C., Golfinopoulos, V., Grande, E. & Halabi, S., Le Rhun, E., Le Saux, O., Leighl, N. B., Lonardi, S., Lorenzen, S., Lorusso, D., Minniti, G., Mountzios, G., Oldenburg, J., Oosting, S. F., Osterlund, P., Perez-Gracia, J. L., Pellat, A., Piperno-Neumann, S., Plummer, R., Porta, C., Punie, K., Ray-Coquard, I., Remon, J., Ruhlmann, C. H., Rutkowski, P., Siu, L. L., Stacchiotti, S., Suarez, C., Suijkerbuijk, K., Taieb, J., Trapani, D., Valachis, A., van Laarhoven, H. W. M., Vogel, A., Zer, A., Pentheroudakis, G., Delaloge, S. & Twelves, C., mei-2026, In: Annals of oncology : official journal of the European Society for Medical Oncology. 37, 5, blz. 608-623 16 blz.

Onderzoeksoutput › › peer review

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review

Interdisciplinary Renal Cell Carcinoma Working Group of the DKG (IAGN), Ahrens, M., Haanen, J., Albiges, L., Goupil, M. G., Boleti, E., Gravis, G., Fléchon, A., Grimm, M. O., Bedke, J., Barthélémy, P., Castellano, D., Mellado, B., Ivanyi, P., Rottey, S., Flörcken, A., Suárez, C., Maroto, J. P., Grünwald, V. & Oosting, S., Kopecky, J., Zschäbitz, S., Boegemann, M., Buchler, T., Niegisch, G., Goebell, P. J., Waddell, T., Joly, F., Priou, F., Retz, M., Siemer, S., Zimmermann, U., Deckbar, D., Burkholder, I., Hartmann, A. & Bergmann, L., 27-mei-2026, (E-pub ahead of print) In: European Journal of Cancer. 243, 9 blz., 116816.

Onderzoeksoutput › › peer review

Real-world effectiveness of molecular-matched therapies in salivary gland cancer

Weijers, J. A. M., van Ruitenbeek, N. J., van Engen-van Grunsven, A. C. H., Driessen, C. M. L., Devriese, L. A., Slingerland, M., Hoeben, A., Oosting, S. F., Schreuder, W. H., Sewnaik, A., van Helvert, S., Schalken, J. A., Verhaegh, G. W. & van Herpen, C. M. L., 1-mei-2026, In: ESMO Open. 11, 5, 13 blz., 106961.

Onderzoeksoutput › › peer review

Comparison of White Light With Narrow Band Imaging Using Flexible Laryngoscopy for the Detection of Local Recurrences After (Chemo)Radiation for Pharyngeal or Laryngeal Cancer: A Randomised Controlled Trial

Scholman, C., Westra, J. M., Zwakenberg, M. A., Wedman, J., van der Vegt, B., Steenbakkers, R. J. H. M., Oosting, S. F., Halmos, G. B., van der Laan, B. F. A. M. & Plaat, B. E. C., 2025, In: Clinical Otolaryngology. 50, 4, blz. 664-673 10 blz.

Onderzoeksoutput › › peer review

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

Cherny, N. I., Oosting, S. F., Dafni, U., Latino, N. J., Galotti, M., Zygoura, P., Dimopoulou, G., Amaral, T., Barriuso, J., Calles, A., Kiesewetter, B., Gomez-Roca, C., Gyawali, B., Piccart, M., Passaro, A., Roitberg, F., Tarazona, N., Trapani, D., Curigliano, G. & Wester, R., Zarkavelis, G., Zielinski, C. & de Vries, E. G. E., aug-2025, In: Annals of Oncology. 36, 8, blz. 866-908 43 blz.

Onderzoeksoutput › › peer review

Genomic distinctions in adolescent and young adult cancer: A comprehensive review

van Putten, J., Lankhorst, L. H., de Langen, A. J., van der Wekken, A. J., Roodhart, J., Bolhuis, K., Oosting, S. F., van Dongen, M., Kok, M., Geurts, M., Koekkoek, J. A. F., Cuppen, E., Nienhuis, H. H. & van der Graaf, W. T. A., nov-2025, In: CANCER TREATMENT REVIEWS. 140, 12 blz., 103021.

Onderzoeksoutput › peer review

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Vermeulen, O. C. B., Brouwer, E., Slart, R. H. J. A., Sandovici, M., Rutgers, A., Hilterman, T. J., Hiddinga, B., Oosting, S. F., Jalving, M., de Heij, A. H., Knapen, D. G., Hospers, G. A. P. & van der Geest, K. S. M., feb-2025, In: Rheumatology (Oxford, England). 64, 2, blz. 771-779 9 blz.

Onderzoeksoutput

Impact of CMV Infection and Cancer Treatment on Vaccine Efficacy in Oncology Patients

Bhatt, D. K., Joshi, M., Visscher, F., Boerma, A., Oosting, S. F., van der Veldt, A. A. M., Hiltermann, T. J. N., van Kessel, C. H. G., Dingemans, A.-M. C., Smit, E. F., Haanen, J. B. A. G., de Vries, E. G. E. & van Baarle, D., 24-aug-2025, MedRxiv, 25 blz.

Onderzoeksoutput: Voordruk ›

Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer

Tannock, I. F., Pe, M. L., Booth, C. M., Brundage, M., Cherny, N. I., Coens, C., Eisenhauer, E. A., Geissler, J., Giesinger, J. M., Gyawali, B., Oosting, S. F., Pond, G. R., Reijneveld, J. C., Soto-Perez-de-Celis, E., Tregear, M. & van der Graaf, W. T. A., sep-2025, In: Lancet Oncology. 26, 9, blz. e499-e507 9 blz.

Onderzoeksoutput › peer review

Pemphigoid diseases as immune-related adverse effect following immune checkpoint inhibitors: A clinical case series of a diverse spectrum

Kotnik, N., Diercks, G. F. H., Jalving, H., Hospers, G. A. P., Oosting, S. F., van Kruchten, M., Hiltermann, T. J. N., Bolling, M. C., Bremer, J., Horváth, B. & Meijer, J. M., jul-2025, In: JAAD case reports. 61, blz. 100-106 7 blz.

Onderzoeksoutput › › peer review